ArticleJAMA cardiology2017
Cost-effectiveness of PCSK9 Inhibitors: Proof in the Modeling.
Robert O Bonow et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it
ArticleJAMA cardiology2017
Robert O Bonow et al.PubMed ↗Publisher ↗
No numbers read from the abstract.